Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt repayments
Ratios

Gain Therapeutics (GANX) Shares Issued (2021 - 2025)

Gain Therapeutics (GANX) has 4 years of Shares Issued data on record, last reported at -$13.9 million in Q3 2025.

  • For Q3 2025, Shares Issued fell 24678.93% year-over-year to -$13.9 million; the TTM value through Sep 2025 reached $41745.0, down 94.85%, while the annual FY2024 figure was $57711.0, 98.52% down from the prior year.
  • Shares Issued reached -$13.9 million in Q3 2025 per GANX's latest filing, down from $8.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $42.6 million in Q1 2021 and bottomed at -$13.9 million in Q3 2025.
  • Average Shares Issued over 4 years is $4.2 million, with a median of $752767.0 recorded in 2023.
  • The widest YoY moves for Shares Issued: up 14697.91% in 2025, down 24678.93% in 2025.
  • A 4-year view of Shares Issued shows it stood at $42.6 million in 2021, then crashed by 98.23% to $752767.0 in 2023, then crashed by 107.45% to -$56089.0 in 2024, then plummeted by 24678.93% to -$13.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$13.9 million in Q3 2025, $8.3 million in Q2 2025, and $5.6 million in Q1 2025.